Table 4.
Patient characteristics at hospital admission for all patients and according to vital status at one-year follow-up
| All Patients (n 499) | Alive (n 407) | Dead (n 92) | ||
|---|---|---|---|---|
| n (%) | n (%) | n (%) | p* | |
| Cardiovascular risk factors | ||||
| Male sex | 259 (51.9) | 216 (53.1) | 43 (46.7) | 0.253 |
| Age, yrs – median (IQR) | 66.0 [52.0–77.0] | 61.5 [50.0–73.0] | 82.0 [75.0–88.0] | < 0.001 |
| BMI, kg/m2 – median (IQR) | 28.7 [25.6–32.8] | 28.7 [25.3–32.5] | 28.7 [26.2–33.7] | 0.562 |
| Ever smoked | 107 (21.4) | 86 (21.1) | 21 (22.8) | 0.773 |
| Hypertension | 245 (49.1) | 179 (43.9) | 66 (71.7) | < 0.001 |
| Dyslipidemia | 171 (34.3) | 127 (31.2) | 44 (47.8) | 0.004 |
| Diabetes mellitus | 103 (20.6) | 70 (17.2) | 33 (35.9) | < 0.001 |
| Comorbidities | ||||
| Cerebrovascular disease | 32 (6.4) | 18 (4.4) | 14 (15.2) | < 0.001 |
| Coronary heart disease | 36 (7.2) | 20 (4.94) |
16 (17.4) ) |
< 0.001 |
| Atrial fibrillation | 38 (7.6) | 20 (4.9) | 18 (19.5) | < 0.001 |
| Chronic heart failure | 26 (5.2) | 12 (2.9) | 14 (15.2) | < 0.001 |
| Chronic kidney disease | 48 (9.6) | 24 (5.9) | 24 (26.1) | < 0.001 |
| Cancer | 67 (13.4) | 48 (11.8) | 19 (20.7) | 0.035 |
| Peripheral vascular disease | 15 (3.0) | 10 (2.5) | 5 (5.4) | 0.171 |
| COPD | 39 (7.8) | 27 (6.6) | 12 (13.0) | 0.065 |
| Laboratory blood tests – median [IQR] | ||||
| Leukocytes, µL×10^3 | 6.50 [4.98–8.44] | 6.36 [4.90–8.05] | 8.00 [5.23–10.4] | 0.001 |
| Lymphocytes, µL×10^3 | 1.06 [0.74–1.50] | 1.12 [0.81–1.55] | 0.76 [0.50–1.20] | < 0.001 |
| Creatinine, mg/dL | 0.90 [0.71–1.12] | 0.87 [0.68–1.06] | 1.09 [0.86–1.60] | < 0.001 |
| Haemoglobin, g/dL | 13.6 [12.3–14.6] | 13.8 [12.6–14.7] | 12.8 [11.2–14.0] | < 0.001 |
| LDH, U/L | 287 [233–378] | 281 [229–359] | 380 [258–461] | < 0.001 |
| C-reactive protein, mg/dL | 7.8 [3.18–14.2] | 6.70 [2.90–12.6] | 11.7 [5.20–22.8] | < 0.001 |
| D-Dimer, ng/mL | 700 [440–1232] | 640 [420–1065] | 1020 [690–2480] | < 0.001 |
| hs-cTnT, ng/L | 0.00 [0.00-19.6] | 0.00 [0.00–14.0] | 31.0 [17.1–64.6] | < 0.001 |
| NT-proBNP. pg/mL | 164 [42.7–514] | 109 [32.2–336] | 1264 [367–4717] | < 0.001 |
IQR, interquartile range; BMI, body mass index; COPD, chronic obstructive pulmonary disease; LDH, lactate dehydrogenase; hs-cTnT, high sensitive cardiac-specific troponin T
*p-value for the comparison between alive vs. dead patients at one year